| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 1 | 0 | |
| Endometrial cancer | 1 | 0 | |
| Growths or tumors (dysplasia) | 1 | 3 | |
| Renal cell cancer | 1 | 3 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Burning mouth syndrome | 1 | |
| Decreased appetite | 1 | |
| Exhaustion | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 3 | |
| Mild | 0 | |
| None | 0 |